Thomas H. Glocer

Chair-Elect

Joins the Informa Board on 1 October 2026; takes up the position of Chair in 2027

Tom Glocer has been an active founder and investor since he stepped down as Chief Executive Officer of Thomson Reuters in December 2011.

He joined Reuters in 1993, holding a number of key leadership positions within the organization prior to becoming CEO in 2001. Tom practiced law at Davis Polk & Wardwell in New York, Paris, and Tokyo from 1984 to 1993.

He is the Lead Director of Merck & Co Inc and Morgan Stanley; Non-Executive Director and Chair of the Audit Committee at Publicis Groupe SA; and Director at K2 Integrity, System, the Atlantic Council and The International Tennis Hall of Fame. He is Executive Chairman and Co-Founder of Capitolis, and Vice Chairman and Co-Founder of Bluevoyant.

Tom is also a Trustee of the Cleveland Clinic and a member of the American Law Institute, the Council on Foreign Relations and the President’s Council on International Activities at Yale University.

Tom holds a bachelor’s degree in political science from Columbia University (1981) and a J.D. from Yale Law School (1984).

.